Andrew Baker

Medicine & Life Sciences

1. Adenoviridae 100%
2. Serogroup 73%
3. Factor X 71%
4. MicroRNAs 63%
5. Endothelial Cells 59%
6. Human Adenoviruses 38%
7. Smooth Muscle Myocytes 38%
8. Genes 36%
9. Blood Vessels 36%
10. Long Noncoding RNA 34%
11. Human Embryonic Stem Cells 33%
12. Genetic Therapy 32%
13. Pulmonary Arterial Hypertension 30%
14. Liver 26%
15. Tropism 24%
16. In Vitro Techniques 23%
17. Vascular Smooth Muscle 21%
18. Tissue Inhibitor of Metalloproteinase-3 19%
19. Capsid 19%
20. Neointima 17%
21. Cardiovascular Diseases 17%
22. Pulmonary Hypertension 16%
23. Dependovirus 16%
24. Viruses 15%
25. Untranslated RNA 15%
26. Vascular Remodeling 15%
27. Gene Expression 14%
28. Atherosclerosis 14%
29. Vascular Diseases 14%
30. Peptides 13%
31. adenovirus receptor 13%
32. Cell Differentiation 12%
33. Adeno-associated virus-2 12%
34. Hepatocytes 12%
35. Fibrosis 12%
36. Hypoxia 12%
37. Pulmonary Artery 11%
38. Lentivirus 11%
39. Lung 11%
40. Kidney 10%
41. Coronary Artery Disease 10%
42. Blood Coagulation Factors 10%
43. Therapeutics 10%
44. Intravenous Injections 10%
45. Heart 9%
46. Enterovirus 9%
47. RNA Sequence Analysis 9%
48. Bacteriophages 9%
49. Serum 9%
50. Myocardial Infarction 9%